Kaijie Biomedical Technology Development Co., Ltd Enterprise history
Over the past decades, chemical experts engaged in peptide drug research and development constitute the core leadership of the company. Professional scientific research ideas are penetrated into all branches and employees of the company.
Chengdu Kaijie Biomedical Technology Development Co., Ltd. is committed to becoming the API enterprise with the strongest scientific research strength and the largest production scale in Asia.
At the beginning of 2007, the company’s board of directors recruited a doctor of production management from a large pharmaceutical company in California and a chemist from the Department of biology of Cambridge University in England.
The optimized management system and production process pushed Chengdu Kaijie to a new height.
In 2001, Chengdu Shengnuo Technology Development Co., Ltd., a group company of Chengdu Kaijie biomedical Development Co., Ltd., was officially established. Its core personnel, that is, the management personnel of each department of the group in the later stage, are the backbone of large domestic Biopharmaceutical Enterprises, and are the first batch of R & D personnel engaged in peptide pharmaceutical industry and chemical production in China.
In the same year, the inherent peptide synthesis technology was organically integrated with the products successfully developed in China to make perfect preparation for the future laboratory construction and new project R & D and production.
In 2002, the renovation of the small laboratory of Chengdu suno Technology Development Co., Ltd. was successful, and the first batch of R & D equipment of the company was purchased. In September 2002, part of the company’s R & D personnel had technical exchanges with the Department of chemistry of the University of Southern California, bringing the international cutting-edge peptide synthesis methods and R & D perspectives to China, and making the company’s R & D strength the first development focus more clear.
In 2003, Chengdu Kaijie biomedical Development Co., Ltd. was established. Its business focuses on peptide product R & D and custom peptide synthesis. There are three new laboratories, and the number of laboratory personnel has increased to 12. At the end of the year, the company introduced the second batch of equipment, including csbio automatic peptide synthesizer and multi flux synthesizer imported from the United States, to adapt to the expanding custom synthesis business.
In 2004, Chengdu suno biopharmaceutical Co., Ltd., a subsidiary of the group, was established, focusing on the production of peptide API. The company’s thymosin, thymopentin and somatostatin raw material products have formed a complete and advanced process, which is well-known in the field of peptide in China!
In 2005, the Group invested 70 million yuan in the purchase of a total area of more than 10 hectares of plant in Dayi Industrial Park to build new plants. At the same time, we will carry out all aspects of integration and marketing, participate in international peptide industry conferences and API exhibitions, and promote the brand of Capgemini to all over the world.
Chengdu Jinuo Chemical Co., Ltd. was established to mainly carry out the production projects of protecting amino acids, resins and chemical raw materials. The Group continues to introduce relevant undergraduate and graduate students from colleges and universities as the training force.
In 2006, the group completed the construction of the new plant and passed the acceptance in the same year, and moved to Dayi Industrial Park. The new plant is divided into three planning areas, the production area has 100000 peptide synthesis workshop, custom peptide synthesis workshop, API workshop, preparation production workshop, etc.
In 2007, the group began to prepare for the approval of related drugs. At the beginning of this year, the company recruited a doctor of production management from a large pharmaceutical company in California and a chemist from the Department of biology of Cambridge University in the United Kingdom, and adopted optimized management system and production process to push Chengdu Kaijie to a new height. In the same year, Chengdu suno technology became one of the fastest growing enterprises in Sichuan Province.
In 2008, Chengdu Kaijie Biomedical Technology Development Co., Ltd. became a long-term supplier of raw materials to 12 local pharmaceutical factories in the United States. And signed supply cooperation agreements with importers in Europe, India and other places. During the year, we participated in Brazil CPHI, Europe CPHI and sponsored American polypeptide conference, and achieved ideal results.
In the same year, thymopentin API obtained GMP certification.
In 2009, Chengdu Kaijie import and export trade Co., Ltd. was established. The establishment of the subsidiary better meets the requirements of the international development of the group’s business. In the same year, suno biopharmaceutical Co., Ltd. obtained a new GMP certification for API and a preparation, and will continue to declare more than 20 new products in the same period.
At that time, it became one of the largest import manufacturers of peptide API in India. The company’s FDA production workshop construction started, and is expected to be completed in 2011 and accept the two-way certification of FDA and SFDA in China.
How many companies are there in peptide api manufacturer in china? The peptide api market is very promising, and the world is encouraging the development of peptide business. There is a peptide api list on the website Biofda.com, which contains various specifications of peptide APIs for customers to choose from. Shengnuo Technology is a peptide api manufacturer located in Chengdu, a city in southwest China. Not only peptide APIs, but also carnosine custom suppliers and cosmetic peptide suppliers
There are many peptide apis manufacture in China, but they are all small-scale companies. The China peptide company such as Sinotech is a leading company in China and has a very high position.
As a Chinese peptide company, Sinotech has been working silently, hoping to become a top peptide company in the world. There are many countries producing peptides in the world, such as bulk drug substance in India, gmp custom peptide in uk, and peptide production in usa. So what is polypeptide? What kind of peptide synthesis supplier should you choose? Follow our website: www.biofda.com, here will tell you the answer.